Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2)
- PMID: 19043732
- DOI: 10.1007/s00417-008-1008-z
Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2)
Abstract
Background: Vasculogenic mimicry (VM) is a tumor angiogenesis process in which highly aggressive melanoma cells form patterned, tubular networks in an in vitro, three-dimensional culture that mimics vasculogenic networks formed by endothelial cells. These cells also express endothelial cell-associated genes such as vascular endothelial-cadherin (VE-cadherin) and are correlated with poor clinical prognosis in patients. However, the molecular underpinnings of this phenomenon remain elusive.
Methods: Three-dimensional cultures of highly and poorly aggressive uveal melanoma cells were observed by inverted light microscope and scanning electronic microscope for VM. RNAi (RNA interference) technology was used to examine whether inhibitor of DNA binding 2 (Id2) was involved in the uveal melanoma vasculogenic mimicry. Western blot analysis showed changes of Id2 and VE-cadherin expression in highly and poorly aggressive melanoma cells in vitro. Migration analysis of highly and poorly aggressive uveal melanoma cells in vitro illuminated the role of Id2 in tumor cells migration.
Results: We show here that a transient knockdown of Id2 by RNA interference abrogates VM and VE-cadherin expression in highly aggressive uveal melanoma cells. Furthermore, inhibition of Id2 changes cellular stability and creates a more dynamic condition. Transfected cells also migrate better than untransfected cells.
Conclusions: This study shows that Id2 is an important regulator of VM. Specifically, Id2 affects VE-cadherin expression, and is critical for the formation of vasculogenic-like networks.
Similar articles
-
Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry.Mol Cancer Ther. 2002 Nov;1(13):1173-9. Mol Cancer Ther. 2002. PMID: 12479698
-
Chromosomal 3p loss and 8q gain drive vasculogenic mimicry via HIF-2α and VE-cadherin activation in uveal melanoma.Cell Death Differ. 2025 Aug;32(8):1473-1483. doi: 10.1038/s41418-025-01469-9. Epub 2025 Feb 26. Cell Death Differ. 2025. PMID: 40000790 Free PMC article.
-
Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells.J Exp Clin Cancer Res. 2009 Sep 7;28(1):124. doi: 10.1186/1756-9966-28-124. J Exp Clin Cancer Res. 2009. PMID: 19735546 Free PMC article.
-
[Vasculogenic mimicry--potential target for tumor therapy].Ai Zheng. 2006 Jul;25(7):914-6. Ai Zheng. 2006. PMID: 16831290 Review. Chinese.
-
Vasculogenic mimicry and tumor angiogenesis.Am J Pathol. 2000 Feb;156(2):361-81. doi: 10.1016/S0002-9440(10)64739-6. Am J Pathol. 2000. PMID: 10666364 Free PMC article. Review.
Cited by
-
Advanced research on vasculogenic mimicry in cancer.J Cell Mol Med. 2015 Feb;19(2):315-26. doi: 10.1111/jcmm.12496. Epub 2015 Jan 19. J Cell Mol Med. 2015. PMID: 25598425 Free PMC article. Review.
-
Endothelial Sphingosine-1-Phosphate Receptor 4 Regulates Blood-Brain Barrier Permeability and Promotes a Homeostatic Endothelial Phenotype.J Neurosci. 2022 Mar 9;42(10):1908-1929. doi: 10.1523/JNEUROSCI.0188-21.2021. Epub 2021 Dec 13. J Neurosci. 2022. PMID: 34903569 Free PMC article.
-
Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.World J Gastrointest Surg. 2010 Apr 27;2(4):117-27. doi: 10.4240/wjgs.v2.i4.117. World J Gastrointest Surg. 2010. PMID: 21160860 Free PMC article.
-
VEGF Induce Vasculogenic Mimicry of Choroidal Melanoma through the PI3k Signal Pathway.Biomed Res Int. 2019 Jul 11;2019:3909102. doi: 10.1155/2019/3909102. eCollection 2019. Biomed Res Int. 2019. PMID: 31380420 Free PMC article.
-
The role of VE-cadherin in osteosarcoma cells.Pathol Oncol Res. 2010 Mar;16(1):111-7. doi: 10.1007/s12253-009-9198-1. Epub 2009 Sep 17. Pathol Oncol Res. 2010. PMID: 19760520
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical